Literature DB >> 19625740

Neuropathologic findings of dementia with lewy bodies (DLB) in a population-based Vantaa 85+ study.

Minna Oinas1, Tuomo Polvikoski, Raimo Sulkava, Liisa Myllykangas, Kati Juva, Irma-Leena Notkola, Sari Rastas, Leena Niinistö, Hannu Kalimo, Anders Paetau.   

Abstract

The consortium on dementia with Lewy bodies has established consensus guidelines for the neuropathologic diagnosis of dementia with Lewy bodies (DLB) including the likelihood that the neuropathologic findings associate with the clinical syndrome. Nevertheless, clinico-pathological correlations remain controversial. We applied the consensus guidelines for determining Lewy-related pathology (LRP) and evaluated the clinical presentation in the prospective, population-based Vantaa 85+ study consisting of individuals at least 85 years of age. LRP was seen in 36% of 304 subjects and categorized as follows: 3% brainstem-predominant, 14% limbic, 15% diffuse neocortical type (4% could not be categorized). The likelihood that the neuropathology predicts the DLB clinical syndrome was low in 6%, intermediate in 13%, and high in 13% of all 304 subjects. In the latter two groups, 77% were demented, 35% had at least one extrapyramidal symptom, and 15% had visual hallucinations. Surprisingly, DLB clinical features associated better with high neurofibrillary stage than with diffuse neocortical LRP. Moreover, the neurofibrillary stage, substantia nigra neuron loss, and grade of Lewy neurites in hippocampal CA2-3 region, each showed a significant association with the extent of LRP. In conclusion, the neuropathologic DLB in this very elderly population was common, but the clinical symptoms tended to associate better with severe neurofibrillary pathology than with extensive LRP.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19625740     DOI: 10.3233/JAD-2009-1169

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  20 in total

1.  Adult Changes in Thought study: dementia is an individually varying convergent syndrome with prevalent clinically silent diseases that may be modified by some commonly used therapeutics.

Authors:  Thomas J Montine; Joshua A Sonnen; Kathleen S Montine; Paul K Crane; Eric B Larson
Journal:  Curr Alzheimer Res       Date:  2012-07       Impact factor: 3.498

2.  Neuropathologic features associated with Alzheimer disease diagnosis: age matters.

Authors:  L E Middleton; L T Grinberg; B Miller; C Kawas; K Yaffe
Journal:  Neurology       Date:  2011-10-26       Impact factor: 9.910

Review 3.  Dementia with Lewy bodies and Parkinson's disease-dementia: current concepts and controversies.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2017-12-08       Impact factor: 3.575

Review 4.  Impact of multiple pathologies on the threshold for clinically overt dementia.

Authors:  Alifiya Kapasi; Charles DeCarli; Julie A Schneider
Journal:  Acta Neuropathol       Date:  2017-05-09       Impact factor: 17.088

Review 5.  Challenges of multimorbidity of the aging brain: a critical update.

Authors:  Kurt A Jellinger; Johannes Attems
Journal:  J Neural Transm (Vienna)       Date:  2014-08-05       Impact factor: 3.575

6.  Cerebrospinal fluid biomarkers for dementia with lewy bodies.

Authors:  Elizabeta B Mukaetova-Ladinska; Rachael Monteith; Elaine K Perry
Journal:  Int J Alzheimers Dis       Date:  2010-10-17

7.  Plasma homocysteine, Alzheimer and cerebrovascular pathology: a population-based autopsy study.

Authors:  Babak Hooshmand; Tuomo Polvikoski; Miia Kivipelto; Maarit Tanskanen; Liisa Myllykangas; Timo Erkinjuntti; Mira Mäkelä; Minna Oinas; Anders Paetau; Philip Scheltens; Elizabeth C W van Straaten; Raimo Sulkava; Alina Solomon
Journal:  Brain       Date:  2013-09       Impact factor: 13.501

Review 8.  Dementia in the oldest old.

Authors:  Zixuan Yang; Melissa J Slavin; Perminder S Sachdev
Journal:  Nat Rev Neurol       Date:  2013-06-04       Impact factor: 42.937

9.  Delirium is a strong risk factor for dementia in the oldest-old: a population-based cohort study.

Authors:  Daniel H J Davis; Graciela Muniz Terrera; Hannah Keage; Terhi Rahkonen; Minna Oinas; Fiona E Matthews; Colm Cunningham; Tuomo Polvikoski; Raimo Sulkava; Alasdair M J MacLullich; Carol Brayne
Journal:  Brain       Date:  2012-08-09       Impact factor: 13.501

10.  Can we clinically diagnose dementia with Lewy bodies yet?

Authors:  Yue Huang; Glenda Halliday
Journal:  Transl Neurodegener       Date:  2013-02-11       Impact factor: 8.014

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.